ExiVex reports human pharmacokinetic data showing that intranasal naloxone EMRX-101 approaches peak plasma concentrations similar to IV with a significantly faster Tmax than the currently approved comparator
ExiVex Biopharma (formerly EmerRx Biopharma), a clinical-stage pharmaceutical company developing a proprietary dual-chamber intranasal drug delivery platform, today announced human…
Men's Health
Bodyweight training remains one of the most effective and accessible ways…
Women's Health
Hair loss has a way of sneaking up on you. One…
Sexual Health
Summary: Gonorrhea and chlamydia share many common symptoms, including unusual discharge…
Skin Care
Nutrition
Latest Articles
ExiVex Biopharma (formerly EmerRx Biopharma), a clinical-stage pharmaceutical company developing a proprietary dual-chamber intranasal drug delivery platform, today…
A chronic pain cycle can begin when actual physical pain disrupts daily life and then slowly shapes how…
A night serum is where the real progress happens. Not because nighttime products are magically stronger, but because…
Summary: Gonorrhea and chlamydia share many common symptoms, including unusual discharge and irritation at the site if infectedMen…
How to eat for your menstrual cycle? Just as the weather moves through the seasons, so does your…
GLP-1 drugs are life-changing. But the science is clear: without resistance training, you lose more than just pounds.…
Interesting Topics
In my opinion, we could all stand to talk about sex more often. But if…